Sequence of genetic alterations in patient 1.

A normal myeloid stem cell that acquires loss of 5q13 and 17p loci confers a prolifertaive advantage. The clone accumulates additional chromosomal alterations after inactivation of the TP53 gene. The resulting acute leukemic clone with the numerous cytogenetic alterations is highly refractory to therapy.